GLP1R and atherosclerosis: We think that reduction of incretin receptor expression levels in arterial cells, at least in part, explain the molecular mechanism of atherosclerosis and indicates the importance of usage of GLP-1 receptor activator at an early stage of atherosclerosis [10].